Published :
Tables : 95
Figures : 30
Category : Healthcare
No. of Pages : 233
Report Code : HC-1169
Infertility Treatment Market is estimated to value over USD 2.8 billion by 2027 end and register CAGR of over 7.8% during the forecast period 2020-2027. Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases. Hefty investments in research and development has created numerous opportunities for the market to prosper. In a recent study, a female mouse successfully conceives and gave birth to an offspring which was healthy and this was done with a synthetic ovary that was created using a 3D printer. This is considered as a breakthrough research thus leading to eminent infertility treatment for women diagnosed with cancer. One of the co-authors, Alexander Rutz, states that these synthetic ovaries are known as biosynthetic organs as they comprise ovarian cells as well as gelatin. The naturally present ovary was removed and replaced by the biosynthetic ovary so that the mouse shall experience its natural ovulation cycle. Female infertility treatment segment is projected to account for the largest market share during the forecast period. There has been a rise in the female infertility rates, increasing awareness among women regarding infertility treatments, increase in the number of fertility centres and availability of multiple treatment options are integral factors contributing to the market growth. Hospitals and surgical clinics segment is expected to exhibit noteworthy growth over the forecast period. Hospitals are firmly bolstered by other departments like neonatal intensive care units. Additionally, hospitals offer a comprehensive maternity treatment even after childbirth. Governmental initiatives to increase the number of multispecialty hospitals with departments to perform infertility treatment procedures like IVF coupled with the increasing number of surgical centres with provisions of surgical procedures for the treatment of infertility is projected to proliferate the market. Major players included in the Infertility Treatment Market are: Cook Group Incorporated Esco Micro Pte. Ltd. Genea Limited Hamilton Throne, Ltd. Ihmedical A/S Irvine Scientific (A Member of Jx Holdings Group) IVFTech Aps Kitazato Corporation Medgyn Products, Inc. Rocket Medical PLC Somatex Medical Technologies GmbH The Baker Company, Inc. The Cooper Companies, Inc. Thermo Fisher Scientific Vitrolife Ab Zeiss Group (Note: The list of the major players will be updated with the latest market scenario and trends) Infertility Treatment Market Segmentation: By Product Equipment Microscopes Imaging Systems Sperm Analyzer Systems Ovum aspiration Pumps Micromanipulator Systems Incubators Gas Analyzers Laser Systems Cryo Systems Media & Consumables Accessories By Procedure In Vitro Fertilization Artificial Insemination Intrauterine Insemination Intracervical Insemination Intratubal Insemination Fertility Surgery Laparoscopy Hysteroscopy Myomectomy Laparotomy Tubal Ligation Reversal Varicocelectomy Microsurgical Reconstruction Vasovasostomy Vasoepididymostomy Others By Patient Type Female Infertility Treatment Male Infertility Treatment By End User Fertility Centres Hospitals and Surgical Clinics Research Institutes Cryobanks By Region North America Europe Asia Pacific Latin America Middle East & Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways Stressful lifestyle and consumption of unhealthy products like tobacco and alcohol are primary reasons of infertility and its soaring rise has increased the demand for market The high costs of treatments and societal pressures on patients can significantly affect the market growth especially in the developing economies Objectives of the Study: To provide with an exhaustive analysis on the shoulder replacement market by product, by procedure, by patient type, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases.
Hefty investments in research and development has created numerous opportunities for the market to prosper. In a recent study, a female mouse successfully conceives and gave birth to an offspring which was healthy and this was done with a synthetic ovary that was created using a 3D printer. This is considered as a breakthrough research thus leading to eminent infertility treatment for women diagnosed with cancer. One of the co-authors, Alexander Rutz, states that these synthetic ovaries are known as biosynthetic organs as they comprise ovarian cells as well as gelatin. The naturally present ovary was removed and replaced by the biosynthetic ovary so that the mouse shall experience its natural ovulation cycle.
Female infertility treatment segment is projected to account for the largest market share during the forecast period. There has been a rise in the female infertility rates, increasing awareness among women regarding infertility treatments, increase in the number of fertility centres and availability of multiple treatment options are integral factors contributing to the market growth. Hospitals and surgical clinics segment is expected to exhibit noteworthy growth over the forecast period. Hospitals are firmly bolstered by other departments like neonatal intensive care units. Additionally, hospitals offer a comprehensive maternity treatment even after childbirth. Governmental initiatives to increase the number of multispecialty hospitals with departments to perform infertility treatment procedures like IVF coupled with the increasing number of surgical centres with provisions of surgical procedures for the treatment of infertility is projected to proliferate the market.
Major players included in the Infertility Treatment Market are:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Infertility Treatment Market Segmentation:
By Product
By Procedure
By Patient Type
By End User
By Region
Competitive Landscape:
FutureWise Key Takeaways
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Infertility Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Infertility Treatment Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Infertility Treatment Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Infertility Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Infertility Treatment Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 Equipment 7.1.1 Microscopes 7.1.2 Imaging Systems 7.1.3 Sperm Analyzer Systems 7.1.4 Ovum aspiration Pumps 7.1.5 Micromanipulator Systems 7.1.6 Incubators 7.1.7 Gas Analyzers 7.1.8 Laser Systems 7.1.9 Cryo Systems 7.2 Media & Consumables 7.3 Accessories 8. Global Infertility Treatment Market, By Procedure Historical Analysis and Forecast 2020-2027 (USD Million) 8.1 In Vitro Fertilization 8.2 Artificial Insemination 8.2.1 Intrauterine Insemination 8.2.2 Intracervical Insemination 8.2.3 Intratubal Insemination 8.3 Fertility Surgery 8.3.1 Laparoscopy 8.3.2 Hysteroscopy 8.3.3 Myomectomy 8.3.4 Laparotomy 8.3.5 Tubal Ligation Reversal 8.3.6 Varicocelectomy 8.3.7 Microsurgical Reconstruction 8.3.8 Vasovasostomy 8.3.9 Vasoepididymostomy 8.4 Others 9. Global Infertility Treatment Market, By Patient Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1 Female Infertility Treatment 9.2 Male Infertility Treatment 10. Global Infertility Treatment Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Fertility Centres 10.2. Hospitals and Surgical Clinics 10.3. Research Institutes 10.4. Cryobanks 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1 Cook Group Incorporated 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 Esco Micro Pte. Ltd. 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Genea Limited 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 Hamilton Throne, Ltd. 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Ihmedical A/S 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Irvine Scientific (A Member of Jx Holdings Group) 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 IVFTech Aps 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Kitazato Corporation 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Medgyn Products, Inc. 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 Rocket Medical PLC 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 Somatex Medical Technologies GmbH 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 The Baker Company, Inc. 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13 The Cooper Companies, Inc. 16.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14 Thermo Fisher Scientific 16.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15 Vitrolife Ab 16.15.1. Company Overview (HQ, Business Segments, Employee Strength) 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16 Zeiss Group 16.16.1. Company Overview (HQ, Business Segments, Employee Strength) 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics